CLINUVELs Managing Director Dr Wolgen Returns to Lead Key Strategic Projects.

CLINUVEL Pharmaceuticals (ASX: CUV) has announced the return of Dr Philippe Wolgen to his full-time role as Managing Director. With his renewed focus and improved health, Dr Wolgen will concentrate on advancing key product development and corporate initiatives over the next three months. His strategic insight, gained during time away from daily operations, will guide the company through its next critical growth phase.

While Dr Wolgen resumes leadership responsibilities, Lachlan Hay will continue to serve as Acting CEO until the end of September 2025. This arrangement ensures stable executive management as CLINUVEL pushes forward with its innovation and expansion agenda. Dr Wolgen emphasized the importance of directing management efforts toward the company’s long-term success and delivering on crucial milestones in the near term. The leadership update marks a pivotal moment for CLINUVEL as it aligns its strategy and resources to support future development and shareholder value.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com